Showing results (31-40 of 254) with videos related to
Sort By:
Pageof 26
Journal of the American Academy of Dermatology|November 14, 2006
Rituximab for the treatment of the skin manifestations of dermatomyositis: a report of 3 casesHope V Dinh, Christopher McCormack, Stephen Hall, et al.European Journal of Haematology|July 5, 2007
Efficacy of single-agent bortezomib vs. single-agent thalidomide in patients with relapsed or refractory multiple myeloma: a systematic comparisonH Miles Prince, Michael Adena, Dell Kingsford Smith, et al.The Australasian Journal of Dermatology|November 21, 2024
Complete skin remission of Sneddon-Wilkinson disease with acalabrutinibHarmeet K Bhullar, Friyana Bhabha, Chris McCormack, et al.Expert Review of Anticancer Therapy|March 28, 2008
Histone deacetylase inhibitors in lymphoma and solid malignanciesWalid Rasheed, Mark Bishton, Ricky W Johnstone, et al.Journal of Personalized Medicine|June 2, 2021
Targeted Approaches to T-Cell LymphomaSean Harrop, Chathuri Abeyakoon, Carrie Van Der Weyden, et al.Leukemia & Lymphoma|May 5, 2021
Management of hydroxyurea resistant or intolerant polycythemia veraIndu Raman, Sant-Rayn Pasricha, H Miles Prince, et al.Journal of Blood Medicine|August 19, 2016
Update and new approaches in the treatment of Castleman diseaseKah-Lok Chan, Stephen Lade, H Miles Prince, et al.The FEBS Journal|April 27, 2016
How do tumor cells respond to HDAC inhibition?Andrea Newbold, Katrina J Falkenberg, H Miles Prince, et al.The Australasian Journal of Dermatology|October 22, 2014
Cutaneous CD30 positive lymphoproliferative disorders with coexistent epithelial neoplasms: Report of two casesKate M Newland, Christopher J McCormack, H Miles Prince, et al.Scandinavian Journal of Gastroenterology|January 29, 2017
Rituximab-induced Crohn's diseasePoornima Varma, Julianne Falconer, Ahmad Aga, et al.Pageof 26